Organized by The International Alliance for Biological Standardization and CIRM, Los Angeles, California- June 5-6, 2018
The meeting will address unresolved issues related to the manufacture and testing of pluripotent stem cell-based therapies. Sessions scheduled over 2 full meeting days include focus on
- Bioanalytics and comparability
- Tumorigenicity testing
- Manufacture, storage and shipment
Key opinion leaders in cell therapy development from industry, government, and academia plus regulatory authorities from the FDA, European Medicines Agency, Japan Pharmaceuticals and Medical Devices Agency, and World Health Organization will attend.
Conference agenda and registration at http://4th-cell-therapy-conference.iabs.org/
June 5 & 6, 2018 — Los Angeles Airport Marriott